Tourmaline Bio Newsroom

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating

Truist Financial analyst Srikripa Devarakonda maintains $Tourmaline Bio(TRML.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 51.6% and a total average return of 2.

Futu NewsSep 11 19:31 · Ratings

Truist Financial Remains a Buy on Tourmaline Bio (TRML)

TipRanksSep 11 19:08 · Ratings

Tourmaline Bio Showcases Promising Candidate in Updated Presentation

TipRanksSep 6 04:51

Piper Sandler Maintains Tourmaline Bio(TRML.US) With Buy Rating, Maintains Target Price $65

Piper Sandler analyst Yasmeen Rahimi maintains $Tourmaline Bio(TRML.US)$ with a buy rating, and maintains the target price at $65.According to TipRanks data, the analyst has a success rate of 37.3%

Futu NewsSep 4 19:33 · Ratings

Tourmaline Bio (TRML) Receives a Buy From Piper Sandler

TipRanksSep 4 18:56 · Ratings

Tourmaline Bio to Present at Upcoming Investor Conferences

Yahoo FinanceSep 3 19:45

Analysts Offer Insights on Healthcare Companies: Tourmaline Bio (TRML), Amicus (FOLD) and Kura Oncology (KURA)

TipRanksAug 13 23:11 · Ratings

Truist Financial Maintains Tourmaline Bio(TRML.US) With Buy Rating, Announces Target Price $15

Truist Financial analyst Srikripa Devarakonda maintains $Tourmaline Bio(TRML.US)$ with a buy rating, and sets the target price at $15.According to TipRanks data, the analyst has a success rate of 45.6

Futu NewsAug 13 21:31 · Ratings

Buy Rating Affirmed for Tourmaline Bio Amid Promising Clinical Trials and Strong Market Potential

TipRanksAug 12 18:19 · Ratings

Tourmaline Bio | 10-Q: Q2 2024 Earnings Report

SECAug 8 20:49 · Announcements

Bullish Tourmaline Bio Insiders Loaded Up On US$643.3k Of Stock

Yahoo FinanceAug 8 20:45

Talaris Therapeutics GAAP EPS of -$0.68

Seeking AlphaAug 8 20:10

Express News | Tourmaline Bio Inc- Q2 Shr Loss of $0.68

BreakingsAug 8 19:38

Tourmaline Bio 2Q Research and Development Expenses $15.7M >TRML

Dow JonesAug 8 19:35

Press Release: Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Dow JonesAug 8 19:30

Express News | Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

BreakingsAug 8 19:30

Express News | Tourmaline Bio Inc - Topline Data Is Expected First Half of 2025

BreakingsAug 3 04:31

Express News | Tourmaline Bio Presents Phase 2 Tranquility Study Design at American Society of Preventive Cardiology (Aspc) Congress 2024

BreakingsAug 3 04:31

Insiders Of Tourmaline Bio Reap Rewards After Their Investment Jumps Another US$90k

Simply Wall StJul 14 22:31

Express News | Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer

BreakingsJun 27 20:05